Literature DB >> 9729467

Insulin stimulates the tyrosine dephosphorylation of docking protein p130cas (Crk-associated substrate), promoting the switch of the adaptor protein crk from p130cas to newly phosphorylated insulin receptor substrate-1.

A Sorokin1, E Reed.   

Abstract

The docking protein p130(cas) (Crk-associated substrate) forms a stable complex with the adaptor protein CrkII in a tyrosine-phosphorylation-dependent manner. Insulin-induced tyrosine phosphorylation of insulin receptor substrates results in the redistribution of CrkII between p130(cas) and insulin receptor substrate-1. A decrease in the association between CrkII and p130(cas) in response to insulin stimulation was detected in CHO cells stably expressing insulin receptor or insulin receptor substrate-1, and in L6 rat myoblasts. Along with the decrease in the association of CrkII with p130(cas), the amount of tyrosine-phosphorylated insulin receptor substrate-1 co-precipitated with CrkII increased in all cell types studied. The insulin-induced decrease in the CrkII-p130(cas) association was further confirmed by Far Western Blot analysis with the Src homology 2 (SH2) domain of CrkII. Insulin regulates the association of CrkII with p130(cas) by tyrosine dephosphorylation of p130(cas) and co-ordinated tyrosine phosphorylation of insulin receptor substrate-1. Tyrosine-phosphorylated insulin receptor substrate-1 serves as a docking protein for multiple adaptor proteins and competes with p130(cas) for CrkII.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9729467      PMCID: PMC1219728          DOI: 10.1042/bj3340595

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  42 in total

1.  Nck associates with the SH2 domain-docking protein IRS-1 in insulin-stimulated cells.

Authors:  C H Lee; W Li; R Nishimura; M Zhou; A G Batzer; M G Myers; M F White; J Schlessinger; E Y Skolnik
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

2.  Identification and characterization of a high-affinity interaction between v-Crk and tyrosine-phosphorylated paxillin in CT10-transformed fibroblasts.

Authors:  R B Birge; J E Fajardo; C Reichman; S E Shoelson; Z Songyang; L C Cantley; H Hanafusa
Journal:  Mol Cell Biol       Date:  1993-08       Impact factor: 4.272

3.  Crk protein binds to PDGF receptor and insulin receptor substrate-1 with different modulating effects on PDGF- and insulin-dependent signaling pathways.

Authors:  A Sorokin; E Reed; N Nnkemere; N O Dulin; J Schlessinger
Journal:  Oncogene       Date:  1998-05-14       Impact factor: 9.867

4.  Role of IRS-1-GRB-2 complexes in insulin signaling.

Authors:  M G Myers; L M Wang; X J Sun; Y Zhang; L Yenush; J Schlessinger; J H Pierce; M F White
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

5.  Tyrosine-phosphorylated epidermal growth factor receptor and cellular p130 provide high affinity binding substrates to analyze Crk-phosphotyrosine-dependent interactions in vitro.

Authors:  R B Birge; J E Fajardo; B J Mayer; H Hanafusa
Journal:  J Biol Chem       Date:  1992-05-25       Impact factor: 5.157

6.  The function of GRB2 in linking the insulin receptor to Ras signaling pathways.

Authors:  E Y Skolnik; A Batzer; N Li; C H Lee; E Lowenstein; M Mohammadi; B Margolis; J Schlessinger
Journal:  Science       Date:  1993-06-25       Impact factor: 47.728

7.  Insulin stimulates the tyrosine dephosphorylation of pp125 focal adhesion kinase.

Authors:  T S Pillay; T Sasaoka; J M Olefsky
Journal:  J Biol Chem       Date:  1995-01-20       Impact factor: 5.157

8.  Skeletal muscle protein tyrosine phosphatase activity and tyrosine phosphatase 1B protein content are associated with insulin action and resistance.

Authors:  J Kusari; K A Kenner; K I Suh; D E Hill; R R Henry
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

9.  Regulation of protein tyrosine phosphatases by insulin and insulin-like growth factor I.

Authors:  K A Kenner; D E Hill; J M Olefsky; J Kusari
Journal:  J Biol Chem       Date:  1993-12-05       Impact factor: 5.157

10.  A novel signaling molecule, p130, forms stable complexes in vivo with v-Crk and v-Src in a tyrosine phosphorylation-dependent manner.

Authors:  R Sakai; A Iwamatsu; N Hirano; S Ogawa; T Tanaka; H Mano; Y Yazaki; H Hirai
Journal:  EMBO J       Date:  1994-08-15       Impact factor: 11.598

View more
  6 in total

1.  Src phosphorylates Cas on tyrosine 253 to promote migration of transformed cells.

Authors:  Gary S Goldberg; David B Alexander; Patricia Pellicena; Zhong-Yin Zhang; Hiroyuki Tsuda; W Todd Miller
Journal:  J Biol Chem       Date:  2003-09-11       Impact factor: 5.157

2.  RACK1, an insulin-like growth factor I (IGF-I) receptor-interacting protein, modulates IGF-I-dependent integrin signaling and promotes cell spreading and contact with extracellular matrix.

Authors:  Ulrich Hermanto; Cong S Zong; Weiqun Li; Lu-Hai Wang
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

3.  Interaction of protein tyrosine phosphatase (PTP) 1B with its substrates is influenced by two distinct binding domains.

Authors:  Shrikrishna Dadke; Jonathan Chernoff
Journal:  Biochem J       Date:  2002-06-01       Impact factor: 3.857

Review 4.  CAS proteins in normal and pathological cell growth control.

Authors:  Nadezhda Tikhmyanova; Joy L Little; Erica A Golemis
Journal:  Cell Mol Life Sci       Date:  2009-11-25       Impact factor: 9.261

5.  Phosphorylation of tyrosine residues 31 and 118 on paxillin regulates cell migration through an association with CRK in NBT-II cells.

Authors:  V Petit; B Boyer; D Lentz; C E Turner; J P Thiery; A M Vallés
Journal:  J Cell Biol       Date:  2000-03-06       Impact factor: 10.539

6.  Carboxy-terminal domain of Cas differentially modulates c-Jun expression, DNA synthesis, and membrane ruffling induced by insulin, EGF, and IGF-1.

Authors:  Sun-Ju Yi; Seong Yun Hwang; Myung-Ju Oh; Kyunghwan Kim; Byung H Jhun
Journal:  Anim Cells Syst (Seoul)       Date:  2018-03-07       Impact factor: 1.815

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.